Open | $28.070 |
Close | $27.470 |
Volume / Avg. | 42.863K / 48.492K |
Day Range | 27.290 - 28.269 |
52 Wk Range | 16.000 - 39.410 |
Market Cap | $401.028M |
P/E Ratio | 72.026 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | % |
Days to Cover | 11.21 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Surmodics (NASDAQ: SRDX) through any online brokerage.
Other companies in Surmodics’s space includes: NeuroPace (NASDAQ:NPCE), Axogen (NASDAQ:AXGN), SI-BONE (NASDAQ:SIBN), Sight Sciences (NASDAQ:SGHT) and Semler Scientific (NASDAQ:SMLR).
The latest price target for Surmodics (NASDAQ: SRDX) was reported by Needham on Thursday, February 1, 2024. The analyst firm set a price target for 47.00 expecting SRDX to rise to within 12 months (a possible 66.84% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Surmodics (NASDAQ: SRDX) is $28.17 last updated March 15, 2024 at 4:03 PM EDT.
There are no upcoming dividends for Surmodics.
Surmodics’s Q2 earnings are confirmed for Wednesday, April 24, 2024.
There is no upcoming split for Surmodics.
Surmodics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.